EPHB6: Difference between revisions
CSV import |
CSV import |
||
| Line 37: | Line 37: | ||
[[Category:Cell signaling]] | [[Category:Cell signaling]] | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 10:04, 17 March 2025
Overview[edit]
EPHB3 is a member of the Eph receptor family, which are a group of receptor tyrosine kinases that play a crucial role in developmental processes, particularly in the nervous system and in the formation of the vascular system. EPHB3 is encoded by the EPHB3 gene in humans.
Structure[edit]
EPHB3, like other Eph receptors, consists of an extracellular region, a single transmembrane segment, and a cytoplasmic tyrosine kinase domain. The extracellular region contains a ligand-binding domain, a cysteine-rich region, and two fibronectin type III repeats. The intracellular region is responsible for signal transduction.
Function[edit]
EPHB3 is involved in various cellular processes, including cell adhesion, cell migration, and cell positioning. It interacts with ephrin-B ligands, which are membrane-bound proteins, to initiate bidirectional signaling. This signaling is crucial for:
- Axon guidance during neural development.
- Angiogenesis, the formation of new blood vessels.
- Tissue boundary formation and maintenance.
Signaling Pathway[edit]
EPHB3 signaling involves both forward and reverse signaling. Forward signaling occurs when EPHB3 binds to its ephrin-B ligands, leading to autophosphorylation and activation of downstream signaling pathways. Reverse signaling occurs in the ephrin-expressing cell, influencing its behavior and function.
Clinical Significance[edit]
Alterations in EPHB3 expression and function have been implicated in various diseases, including:
- Cancer: EPHB3 has been shown to play a role in tumor progression and metastasis.
- Neurodevelopmental disorders: Abnormal EPHB3 signaling can affect brain development and function.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms of EPHB3 signaling and its role in disease. Targeting EPHB3 and its pathways is being explored as a potential therapeutic strategy in cancer and other diseases.
Also see[edit]

